$AORT
ARTIVION, INC.

2019 Q4 Form 10-Q Financial Statement

#000078419919000158 Filed on October 31, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $69.70M $67.88M $64.60M
YoY Change 2.8% 5.08% 46.82%
Cost Of Revenue $22.66M $21.88M
YoY Change 3.54% 54.8%
Gross Profit $46.55M $45.22M $42.71M
YoY Change 3.01% 5.87% 43.04%
Gross Profit Margin 66.79% 66.62% 66.12%
Selling, General & Admin $34.26M $32.87M
YoY Change 4.22% 32.78%
% of Gross Profit 75.76% 76.96%
Research & Development $6.259M $5.225M
YoY Change 19.79% 22.17%
% of Gross Profit 13.84% 12.23%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $40.52M $38.10M
YoY Change 6.36% 31.22%
Operating Profit $4.704M $4.618M
YoY Change 1.86% 457.06%
Interest Expense $3.600M $4.100M
YoY Change -12.2% 381.79%
% of Operating Profit 76.53% 88.78%
Other Income/Expense, Net -$2.400M $1.542M
YoY Change -255.64% -7442.86%
Pretax Income -$992.0K $2.108M
YoY Change -147.06% 9938.1%
Income Tax -$858.0K $543.0K
% Of Pretax Income 25.76%
Net Earnings -$681.0K -$134.0K $1.565M
YoY Change -12.24% -108.56% 18.11%
Net Earnings / Revenue -0.98% -0.2% 2.42%
Basic Earnings Per Share $0.00 $0.04
Diluted Earnings Per Share -$0.02 $0.00 $0.04
COMMON SHARES
Basic Shares Outstanding 37.50M 37.26M 36.53M
Diluted Shares Outstanding 37.26M 37.61M

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $33.77M $36.69M $34.56M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $53.07M $48.40M $46.15M
Prepaid Expenses
Receivables $52.94M $50.55M
Other Receivables $2.921M $4.322M $3.974M
Total Short-Term Assets $187.4M $181.4M $174.0M
YoY Change 4.59% 4.26%
LONG-TERM ASSETS
Property, Plant & Equipment $32.15M $30.43M $32.07M
YoY Change 3.62% -5.11%
Goodwill $186.7M $183.4M $188.1M
YoY Change -1.1% -2.53%
Intangibles $121.3M
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.21M $14.06M $12.12M
YoY Change 79.35% 16.09%
Total Long-Term Assets $418.3M $411.2M $395.7M
YoY Change 6.72% 3.92%
TOTAL ASSETS
Total Short-Term Assets $187.4M $181.4M $174.0M
Total Long-Term Assets $418.3M $411.2M $395.7M
Total Assets $605.7M $592.6M $569.7M
YoY Change 6.05% 4.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.796M $7.455M $5.941M
YoY Change 29.8% 25.48%
Accrued Expenses $6.733M
YoY Change -6.4%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $1.164M $1.144M $1.266M
YoY Change 0.34% -9.64%
Total Short-Term Liabilities $45.20M $42.19M $30.75M
YoY Change 30.91% 37.21%
LONG-TERM LIABILITIES
Long-Term Debt $214.6M $214.8M $216.6M
YoY Change -0.53% -0.82%
Other Long-Term Liabilities $6.581M $15.37M $19.44M
YoY Change -4.19% -20.94%
Total Long-Term Liabilities $221.2M $230.2M $236.0M
YoY Change -0.65% -2.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.20M $42.19M $30.75M
Total Long-Term Liabilities $221.2M $230.2M $236.0M
Total Liabilities $320.0M $315.1M $292.9M
YoY Change 8.09% 7.58%
SHAREHOLDERS EQUITY
Retained Earnings $36.70M $37.39M $35.74M
YoY Change 4.92% 4.6%
Common Stock $272.2M $269.6M $258.9M
YoY Change 4.38% 4.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $285.7M $277.5M $276.8M
YoY Change
Total Liabilities & Shareholders Equity $605.7M $592.6M $569.7M
YoY Change 6.05% 4.02%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$681.0K -$134.0K $1.565M
YoY Change -12.24% -108.56% 18.11%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000784199
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13165
dei Entity Registrant Name
EntityRegistrantName
CRYOLIFE INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2417093
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2662000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
257000
dei Trading Symbol
TradingSymbol
CRY
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37503707
CY2019Q3 us-gaap Revenues
Revenues
67881000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6259000
dei Entity Address Address Line1
EntityAddressAddressLine1
1655 Roberts Boulevard, NW
dei Entity Address City Or Town
EntityAddressCityOrTown
Kennesaw
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30144
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
419-3355
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2018Q3 us-gaap Revenues
Revenues
64598000
us-gaap Revenues
Revenues
206525000
us-gaap Revenues
Revenues
195042000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22659000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21884000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70064000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
67249000
CY2019Q3 us-gaap Gross Profit
GrossProfit
45222000
CY2018Q3 us-gaap Gross Profit
GrossProfit
42714000
us-gaap Gross Profit
GrossProfit
136461000
us-gaap Gross Profit
GrossProfit
127793000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34259000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32871000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105402000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
104946000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5225000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17648000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16314000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
40518000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
38096000
us-gaap Operating Expenses
OperatingExpenses
123050000
us-gaap Operating Expenses
OperatingExpenses
121260000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4704000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4618000
us-gaap Operating Income Loss
OperatingIncomeLoss
13411000
us-gaap Operating Income Loss
OperatingIncomeLoss
6533000
CY2019Q3 cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
3555000
CY2018Q3 cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
4104000
cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
11260000
cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
11863000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
259000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
52000
us-gaap Investment Income Interest
InvestmentIncomeInterest
608000
us-gaap Investment Income Interest
InvestmentIncomeInterest
141000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2400000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1542000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-992000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2108000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4932000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-858000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
543000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2304000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2868000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1565000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Net Income Loss
NetIncomeLoss
-2064000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36526000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37065000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36331000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37255000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37610000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37850000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36331000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1565000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Net Income Loss
NetIncomeLoss
-2064000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8017000
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-514000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8803000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5140000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8151000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1051000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6402000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7204000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36685000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41489000
CY2019Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
492000
CY2018Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
747000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50550000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47108000
CY2019Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4322000
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4324000
CY2019Q3 us-gaap Inventory Net
InventoryNet
48403000
CY2018Q4 us-gaap Inventory Net
InventoryNet
45478000
CY2019Q3 cry Deferred Preservation Costs
DeferredPreservationCosts
32352000
CY2018Q4 cry Deferred Preservation Costs
DeferredPreservationCosts
33174000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8550000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6848000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
181354000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
179168000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30434000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31028000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21841000
CY2019Q3 us-gaap Goodwill
Goodwill
183368000
CY2018Q4 us-gaap Goodwill
Goodwill
188781000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
107863000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
118184000
CY2019Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
49806000
CY2018Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
41897000
CY2019Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3872000
CY2018Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4111000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14064000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7922000
CY2019Q3 us-gaap Assets
Assets
592602000
CY2018Q4 us-gaap Assets
Assets
571091000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7455000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7547000
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11628000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10733000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1144000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1160000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5270000
CY2019Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2324000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2250000
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14369000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12833000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
42190000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34523000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
214793000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
215721000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18046000
CY2019Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
24699000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
27267000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15373000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18513000
CY2019Q3 us-gaap Liabilities
Liabilities
315101000
CY2018Q4 us-gaap Liabilities
Liabilities
296024000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38988000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38463000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
390000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
385000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
269192000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
260361000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37385000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34984000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14875000
CY2019Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1484000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
271505000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
276825000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
277058000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6072000
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1484000
CY2018Q4 cry Deferred Preservation Costs
DeferredPreservationCosts
33174000
CY2019Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14591000
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14591000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
277501000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
275067000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
592602000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
571091000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Net Income Loss
NetIncomeLoss
-2064000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13257000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13636000
us-gaap Share Based Compensation
ShareBasedCompensation
6581000
us-gaap Share Based Compensation
ShareBasedCompensation
4685000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5021000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1330000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4496000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2310000
cry Increase Decrease In Deferred Preservation Costs And Inventories
IncreaseDecreaseInDeferredPreservationCostsAndInventories
3864000
cry Increase Decrease In Deferred Preservation Costs And Inventories
IncreaseDecreaseInDeferredPreservationCostsAndInventories
-1697000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3020000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2481000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1113000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12473000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14767000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-640000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5222000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4275000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
531000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
722000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20753000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4997000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2072000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2098000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4519000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3793000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2723000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2085000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-560000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-888000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-836000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1278000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1763000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1473000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5059000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5442000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40753000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37177000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35311000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
282153000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8017000
cry Obligated Minimum Purchase Amount Year Of Start
ObligatedMinimumPurchaseAmountYearOfStart
2020
cry Distribution Agreement Amortization Period
DistributionAgreementAmortizationPeriod
P5Y
CY2019Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
358000
CY2019Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2316000
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2192000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8151000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2620000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53000
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
885000
CY2019Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
59000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
277501000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
275067000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8803000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6402000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7039000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3057000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1463000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
2723000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
277501000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1565000
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-514000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1051000
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1693000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2099000
CY2018Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
751000
CY2018Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
274000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5048000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2454000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1339000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
2085000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
276825000
us-gaap Basis Of Accounting
BasisOfAccounting
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">1. Basis of Presentation  </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying summary consolidated financial statements include the accounts of CryoLife, Inc. and its subsidiaries (“CryoLife,” the “Company,” “we,” or “us”). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Summary Consolidated Balance Sheet as of December 31, 2018 has been derived from audited financial statements. The accompanying unaudited summary consolidated financial statements as of, and for the three and nine months ended, September 30, 2019 and 2018 have been prepared in accordance with (i) accounting principles generally accepted in the U.S. for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, such statements do not include all of the information and disclosures required by accounting principles generally accepted in the U.S. for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. These summary consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in CryoLife’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on February 26, 2019.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">New Accounting Standards</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Recently Adopted</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of January 1, 2019 we adopted the Accounting Standards Codification (“ASC”) Topic 842, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Leases</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (“ASC 842”). The final guidance requires lessees to recognize a right-of-use asset and a lease liability for all leases (with the exception of short-term leases) at the commencement date and recognize expenses on their income statements similar to former Topic 840, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Leases</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. We used the modified retrospective approach, which allows application of the standard at the adoption date rather than at the beginning of the earliest comparative period presented. The adoption of this standard resulted in the recognition of operating lease agreements with a net present value of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">22.7</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and corresponding right-of-use assets obtained in the same amount at January 1, 2019. See Note 8 for further discussion of leases.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Not Yet Effective</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASC Update No. 2016-13, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> The purpose of Update No. 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. Update No. 2016-13 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods and early adoption is permitted. We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations.</span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span>
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
358000
CY2019Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
358000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3400000
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
23200000
CY2019Q3 us-gaap Goodwill
Goodwill
183368000
CY2018Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
17381000
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5183000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3858000
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23636000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24239000
CY2019Q3 us-gaap Inventory Net
InventoryNet
48403000
CY2018Q4 us-gaap Inventory Net
InventoryNet
45478000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2018Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2019Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2019Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
19584000
CY2019Q3 cry Deferred Preservation Costs
DeferredPreservationCosts
32352000
CY2019Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
11800000
CY2018Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
11200000
CY2019Q3 us-gaap Goodwill
Goodwill
183368000
CY2018Q4 us-gaap Goodwill
Goodwill
188781000
CY2018Q4 us-gaap Goodwill
Goodwill
188781000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-5413000
cry Number Of Subleases
NumberOfSubleases
2
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2660000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2707000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7796000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8195000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3029000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
11773000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11750000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
11205000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10797000
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
10569000
CY2019Q3 cry Finite Lived Intangible Assets Amortization Expense Estimate
FiniteLivedIntangibleAssetsAmortizationExpenseEstimate
59123000
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.87
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
23.75
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.58
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
2000
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
2000000.0
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
900000
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1400000
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1400000
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4200000
CY2019Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
20800000
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2019Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2400000
cry Lessee Operating Lease Option To Terminate Period
LesseeOperatingLeaseOptionToTerminatePeriod
P29Y
cry Operating Lease Termination Option Notice Period Requirement
OperatingLeaseTerminationOptionNoticePeriodRequirement
P2Y
CY2018 us-gaap Sublease Income
SubleaseIncome
910000
CY2019Q3 cry Operating Lease Right Of Use Assets At Cost
OperatingLeaseRightOfUseAssetsAtCost
25576000
CY2019Q3 cry Operating Lease Right Of Use Assets Accumulated Amortization
OperatingLeaseRightOfUseAssetsAccumulatedAmortization
3735000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21841000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5270000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18046000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
23316000
CY2019Q3 cry Finance Lease Right Of Use Asset At Cost
FinanceLeaseRightOfUseAssetAtCost
6750000
CY2019Q3 cry Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1079000
CY2019Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5671000
CY2019Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
636000
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5144000
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
5780000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2019Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P11Y
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054
CY2019Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.020
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
188000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
608000
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
30000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
93000
CY2019Q3 cry Finance Lease Cost
FinanceLeaseCost
218000
cry Finance Lease Cost
FinanceLeaseCost
701000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1717000
us-gaap Operating Lease Cost
OperatingLeaseCost
4870000
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
227000
us-gaap Sublease Income
SubleaseIncome
679000
CY2019Q3 us-gaap Lease Cost
LeaseCost
1708000
us-gaap Lease Cost
LeaseCost
4892000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
91000
us-gaap Operating Lease Payments
OperatingLeasePayments
5004000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
561000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
215721000
CY2019Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
256000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1347000
CY2019Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear
227000
CY2019Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
554000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6632000
CY2019Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Next Twelve Months
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInNextTwelveMonths
921000
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
609000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5908000
CY2019Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInTwoYears
930000
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
557000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3459000
CY2019Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInThreeYears
316000
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
557000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2300000
CY2019Q3 cry Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
3900000
CY2019Q3 cry Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
7228000
CY2019Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
6433000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
26874000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
2394000
CY2019Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
653000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3558000
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
5780000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
23316000
CY2019Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
636000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5270000
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5144000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18046000
CY2019Q3 cry Debt Instrument Debt Default Interest Rate
DebtInstrumentDebtDefaultInterestRate
0.0200
CY2019Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0535
us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.0050
cry Line Of Credit Facility Percentage Threshold Of Principal Amount Outstanding
LineOfCreditFacilityPercentageThresholdOfPrincipalAmountOutstanding
0.25
CY2019Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
223785000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
225953000
CY2019Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7848000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9072000
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
215937000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
216881000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1144000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1160000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
214793000
CY2019Q3 us-gaap Interest Expense
InterestExpense
3600000
CY2018Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
15000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
17000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67881000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64598000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
206525000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195042000
us-gaap Interest Expense
InterestExpense
11300000
CY2018Q3 us-gaap Interest Expense
InterestExpense
4100000
us-gaap Interest Expense
InterestExpense
11900000
CY2019Q3 us-gaap Loss Contingency Accrual Product Liability Gross
LossContingencyAccrualProductLiabilityGross
1900000
CY2018Q4 us-gaap Loss Contingency Accrual Product Liability Gross
LossContingencyAccrualProductLiabilityGross
1700000
CY2019Q3 us-gaap Reinsurance Receivables Incurred But Not Reported Claims
ReinsuranceReceivablesIncurredButNotReportedClaims
943000
CY2018Q4 us-gaap Reinsurance Receivables Incurred But Not Reported Claims
ReinsuranceReceivablesIncurredButNotReportedClaims
693000
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2620000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1693000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7039000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5051000
CY2019Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
158000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
458000
CY2018Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
125000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
363000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1565000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Net Income Loss
NetIncomeLoss
-2064000
CY2019Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-1000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000
CY2019Q3 us-gaap Gross Profit
GrossProfit
45222000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36526000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37065000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36331000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1565000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-20000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-133000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1550000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2384000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2044000
us-gaap Net Income Loss
NetIncomeLoss
-2064000
CY2019Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-1000
CY2018Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
14000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
16000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-20000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-133000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1551000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2385000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2044000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36526000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37065000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36331000
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1084000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
785000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37255000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37610000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37850000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36331000
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
123000
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019Q3 us-gaap Revenues
Revenues
67881000
CY2018Q3 us-gaap Revenues
Revenues
64598000
us-gaap Revenues
Revenues
206525000
us-gaap Revenues
Revenues
195042000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22659000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21884000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70064000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
67249000
CY2018Q3 us-gaap Gross Profit
GrossProfit
42714000
us-gaap Gross Profit
GrossProfit
136461000
us-gaap Gross Profit
GrossProfit
127793000
CY2019Q3 us-gaap Revenues
Revenues
67881000
CY2018Q3 us-gaap Revenues
Revenues
64598000
us-gaap Revenues
Revenues
206525000
us-gaap Revenues
Revenues
195042000

Files In Submission

Name View Source Status
0000784199-19-000158-index-headers.html Edgar Link pending
0000784199-19-000158-index.html Edgar Link pending
0000784199-19-000158.txt Edgar Link pending
0000784199-19-000158-xbrl.zip Edgar Link pending
cry-20190930.xsd Edgar Link pending
cry-20190930x10q.htm Edgar Link pending
cry-20190930x10q_htm.xml Edgar Link completed
cry-20190930xex10_1.htm Edgar Link pending
cry-20190930xex10_2.htm Edgar Link pending
cry-20190930xex31_1.htm Edgar Link pending
cry-20190930xex31_2.htm Edgar Link pending
cry-20190930xex32.htm Edgar Link pending
cry-20190930_cal.xml Edgar Link unprocessable
cry-20190930_def.xml Edgar Link unprocessable
cry-20190930_lab.xml Edgar Link unprocessable
cry-20190930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending